Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Quarterly results
CC transcript
Consulting agrmnt
Appointed COO
|
|
CEPHALON INC (CEPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/02/2011 |
8-K
| Form 8-K - Current report |
| 03/25/2011 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Cephalon Announces Definitive Agreement to Acquire Gemin X",
"Cephalon Wins FENTORA Patent Suit Against Watson FRAZER, Pa., March 24, 2011 — Cephalon, Inc. announced that today the United States District Court in Delaware upheld the validity of Cephalon's U.S. Patent Number 6,264,981 patent and found that Watson Pharmaceuticals, Inc's proposed generic version of FENTORA® infringes that patent. The Court also denied Watson's motion to vacate a previously entered injunction preventing Watson from marketing its product. “We are pleased with the court's ruling upholding the validity of our patent, as well as its finding that Watson's product infringes that patent,” said Jerry Pappert, Executive Vice President and General Counsel of Cephalon. This decision pertained to patent litigation brought by Cephalon and its wholly-owned subsidiary CIMA Labs, Inc. a..." |
|
|
|